D.E. Shaw & Co
ISO

D.E. Shaw & Co’s IsoPlexis Corporation Common Stock ISO Stock Holding History

D.E. Shaw & Co’s Portfolio ISO Stock Details ISO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,404
Closed -$46K – 5965
2022
Q1 		$46K Sell
13,404
-39,437
-75% -$228K ﹤0.01% 5160
2021
Q4 		$486K Buy
+52,841
New +$586K ﹤0.01% 4420

Other funds holding ISO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's ISO Position: Q2 2022 in Review

D.E. Shaw & Co sold out of IsoPlexis Corporation Common Stock (ISO) in Q2 2022, closing a stake of 13,404 shares — an estimated $46K sold.

D.E. Shaw & Co first reported a position in ISO in Q4 2021 and held it in 2 quarters. The position peaked at $486K in Q4 2021. 29 funds tracked by Wall St. Rank hold ISO as of Q2 2022.

  • D.E. Shaw & Co reported no remaining IsoPlexis Corporation Common Stock position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,404 IsoPlexis Corporation Common Stock shares in Q2 2022, an estimated $46K.
  • D.E. Shaw & Co first reported a position in IsoPlexis Corporation Common Stock in Q4 2021 and held it in 2 quarters.
  • D.E. Shaw & Co's IsoPlexis Corporation Common Stock position peaked at $486K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held IsoPlexis Corporation Common Stock as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.